AGP Executive Report
Last update: 12 hours agoPTSD Treatment Breakthrough: A German trial found prescription THC (dronabinol) cut PTSD nightmare burden, with more than one-third of patients reporting complete disappearance of nightmares, adding momentum for cannabinoid-based mental health care. Dementia Quality-of-Life Data: Kentucky researchers reported that a CBD+THC combo reduced agitation scores in late-stage dementia patients, highlighting a potential new option where few exist. Veterinary CBD Expansion: Argent BioPharma’s CannEpil is moving into US animal health via a veterinary development program targeting companion-animal oncology and chronic pain, with FDA CVM steps underway. Workplace Cannabis Reality Check: New employer testing data shows fewer companies are screening for cannabis, even as positivity rates in urine and hair samples rise. Regulation Watch (Texas/NC): Texas’ hemp-THC crackdown is being challenged in federal court, while North Carolina Gov. Josh Stein argues for a regulated adult THC market instead of a broad hemp ban. Education & Industry Growth: UNLV launched online cannabis career certificate programs, signaling continued mainstreaming of cannabis workforce training.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
